The recognition that adipocytes play an indispensable role in metabolic function also provided an impetus for the development of pharmacologic agents targeting adipose tissue specifically in efforts to improve insulin sensitivity and blood glucose control [6,7] as part of the continuing struggle to combat type 2 diabetes worldwide. Here, INS is linked to type 2 diabetes mellitus.